MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children.Gian Paolo Tonini, Bruno De Bernardi, Andrea Pession et al.|Journal of Clinical Oncology|1997Cited by 113
Atypical teratoid/rhabdoid tumor in adults: a systematic review of the literature with meta-analysis and additional reports of 4 casesGiuseppe Broggi, Manila Antonelli, Francesca Gianno et al.|Journal of Neuro-Oncology|2022Cited by 26
Loss of heterozygosity for chromosome 1p in familial neuroblastomaGian Paolo Tonini, Paola Scaruffi, Crocifissa Lo Cunsolo et al.|European Journal of Cancer|1997Cited by 7
[The identification of minimal residual disease in the bone marrow and peripheral blood in neuroblastoma. The prognostic and therapeutic implications].Lawrence Faulkner, Bruno De Bernardi, Anna Tamburini et al.|PubMed|1998Cited by 1
Identificazione della malattia residua minima nel midollo e nel sangue periferico nel neuroblastoma. Implicazioni prognostiche e terapeutiche.Lawrence Faulkner, Bruno De Bernardi, A. Tamburini et al.|Unknown|1998Cited by 0